Clinical Trials Logo

Sickle Cell Thalassemia clinical trials

View clinical trials related to Sickle Cell Thalassemia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04579926 Completed - Sickle Cell Disease Clinical Trials

PINPOINT: Gaming Technology for SCD Pain

Pinpoint II
Start date: September 19, 2018
Phase: N/A
Study type: Interventional

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet programs to assist SCD adolescents with better identification and communication about pain are lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve self-care. Pinpoint is an interactive gaming app that will be tested in a Phase II project to determine whether the app assists SCD teens with improving their communication and identification skills for pain self-report.

NCT ID: NCT00736060 Completed - Sickle Cell Anemia Clinical Trials

Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

Start date: May 2008
Phase: N/A
Study type: Observational

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

NCT ID: NCT00512564 Completed - Sickle Cell Anemia Clinical Trials

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia

Start date: September 2008
Phase: N/A
Study type: Observational

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't developed significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpose of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and laboratory studies including Non Transferrin Binding Iron, Labile Iron and Hepcidin, in order to determine the cardiac and liver iron.

NCT ID: NCT00512226 Completed - Sickle Cell Anemia Clinical Trials

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

Start date: September 2007
Phase: N/A
Study type: Interventional

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't develope significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpouse of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and cardiac T2*MRI in order to determine the cardiac and liver iron.

NCT ID: NCT00480974 Completed - Sickle Cell Anemia Clinical Trials

Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea

Start date: May 2007
Phase: N/A
Study type: Observational

Hydroxyurea was found to be a good treatment in adult patients with sickle cell anemia with significant decrease in the frequency of vaso-occlusive crises and other crises related to SCA. Several studies were published with relative short term follow up in pediatric and young adult age. The purpose of this study is to assess the long term follow up in a group of patients that initiated Hydroxyurea treatment in childhood.